RU94022258A - Новые сульфониламинопиримидины - Google Patents
Новые сульфониламинопиримидиныInfo
- Publication number
- RU94022258A RU94022258A RU94022258/04A RU94022258A RU94022258A RU 94022258 A RU94022258 A RU 94022258A RU 94022258/04 A RU94022258/04 A RU 94022258/04A RU 94022258 A RU94022258 A RU 94022258A RU 94022258 A RU94022258 A RU 94022258A
- Authority
- RU
- Russia
- Prior art keywords
- compounds
- sulfonylaminopyrimidines
- new
- treatment
- description
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/69—Benzenesulfonamido-pyrimidines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Ophthalmology & Optometry (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Pyridine Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Соединения общей формулыгде R- R, R, R, X, Y, Z, m и n имеют указанное в описании значение, могут применяться в качестве лечебных средств, прежде всего для лечения и профилактики состояний, связанных с активностью эндотелия.
Claims (1)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH924/93 | 1993-03-26 | ||
CH1924/93 | 1993-06-28 | ||
CH192493 | 1993-06-28 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU94022258A true RU94022258A (ru) | 1996-04-20 |
RU2142457C1 RU2142457C1 (ru) | 1999-12-10 |
Family
ID=4221780
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU94022258/04A RU2142457C1 (ru) | 1993-06-28 | 1994-06-27 | Сульфониламинопиримидины и фармацевтический препарат |
Country Status (41)
Country | Link |
---|---|
US (1) | US5541186A (ru) |
EP (1) | EP0633259B1 (ru) |
JP (1) | JP2545200B2 (ru) |
KR (1) | KR100338905B1 (ru) |
CN (1) | CN1050839C (ru) |
AT (1) | ATE175669T1 (ru) |
AU (1) | AU678467B2 (ru) |
BG (1) | BG61691B1 (ru) |
BR (2) | BR9402558A (ru) |
CA (1) | CA2125730C (ru) |
CO (1) | CO4230230A1 (ru) |
CZ (1) | CZ287184B6 (ru) |
DE (1) | DE59407626D1 (ru) |
DK (1) | DK0633259T3 (ru) |
EC (1) | ECSP941111A (ru) |
ES (1) | ES2127850T3 (ru) |
FI (1) | FI112944B (ru) |
GR (1) | GR3029874T3 (ru) |
HR (1) | HRP940370B1 (ru) |
HU (2) | HUT67636A (ru) |
IL (1) | IL110089A (ru) |
IS (1) | IS4185A (ru) |
LT (1) | LT3723B (ru) |
LV (1) | LV11175B (ru) |
MY (1) | MY110871A (ru) |
NO (1) | NO306403B1 (ru) |
NZ (1) | NZ260842A (ru) |
PE (1) | PE56794A1 (ru) |
PH (1) | PH30688A (ru) |
PL (2) | PL175771B1 (ru) |
RO (1) | RO114325B1 (ru) |
RU (1) | RU2142457C1 (ru) |
SG (1) | SG43888A1 (ru) |
SI (1) | SI0633259T1 (ru) |
SK (1) | SK280736B6 (ru) |
SV (1) | SV1994000028A (ru) |
TW (1) | TW394761B (ru) |
UA (1) | UA40578C2 (ru) |
UY (1) | UY23797A1 (ru) |
YU (1) | YU40794A (ru) |
ZA (1) | ZA944434B (ru) |
Families Citing this family (67)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5514696A (en) * | 1992-05-06 | 1996-05-07 | Bristol-Myers Squibb Co. | Phenyl sulfonamide endothelin antagonists |
US6743783B1 (en) * | 1993-12-01 | 2004-06-01 | Marine Polymer Technologies, Inc. | Pharmaceutical compositions comprising poly-β-1→4-N-acetylglucosamine |
US6063911A (en) * | 1993-12-01 | 2000-05-16 | Marine Polymer Technologies, Inc. | Methods and compositions for treatment of cell proliferative disorders |
US5612359A (en) * | 1994-08-26 | 1997-03-18 | Bristol-Myers Squibb Company | Substituted biphenyl isoxazole sulfonamides |
EP0790826A4 (en) | 1994-11-16 | 1998-11-11 | Synaptic Pharma Corp | DYHYDROPYRIMIDINE AND THEIR USE |
US6268369B1 (en) | 1994-11-16 | 2001-07-31 | Synaptic Pharmaceutical Corporation | 5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines |
CA2162630C (en) * | 1994-11-25 | 2007-05-01 | Volker Breu | Sulfonamides |
TW313568B (ru) * | 1994-12-20 | 1997-08-21 | Hoffmann La Roche | |
WO1996020177A1 (fr) * | 1994-12-28 | 1996-07-04 | Kowa Co., Ltd. | Derives pyrimidiniques |
US5780473A (en) * | 1995-02-06 | 1998-07-14 | Bristol-Myers Squibb Company | Substituted biphenyl sulfonamide endothelin antagonists |
US5760038A (en) * | 1995-02-06 | 1998-06-02 | Bristol-Myers Squibb Company | Substituted biphenyl sulfonamide endothelin antagonists |
US5573762A (en) * | 1995-04-24 | 1996-11-12 | Genentech, Inc. | Use of leukemia inhibitory factor specific antibodies and endothelin antagonists for treatment of cardiac hypertrophy |
US5739333A (en) * | 1995-05-16 | 1998-04-14 | Tanabe Seiyaku Co., Ltd. | Sulfonamide derivative and process for preparing the same |
US5846990A (en) * | 1995-07-24 | 1998-12-08 | Bristol-Myers Squibb Co. | Substituted biphenyl isoxazole sulfonamides |
EP0852226B1 (en) * | 1995-09-06 | 2003-11-19 | Kowa Co. Ltd. | Pyrimidine derivatives |
JPH09124620A (ja) * | 1995-10-11 | 1997-05-13 | Bristol Myers Squibb Co | 置換ビフェニルスルホンアミドエンドセリン拮抗剤 |
CZ260596A3 (en) * | 1995-10-12 | 1997-12-17 | Hoffmann La Roche | Sulfonamide derivative, process of its preparation and pharmaceutical composition containing thereof |
US6228861B1 (en) | 1995-11-16 | 2001-05-08 | Synaptic Pharmaceutical Corporation | Dihydropyrimidines and uses thereof |
ES2156305T3 (es) * | 1995-12-20 | 2001-06-16 | Yamanouchi Pharma Co Ltd | Derivados de ariletenosulfonamida y composiciones de farmacos que los contienen. |
AU717230B2 (en) | 1996-02-20 | 2000-03-23 | Bristol-Myers Squibb Company | Methods for the preparation of biphenyl isoxazole sulfonamides |
US5856507A (en) * | 1997-01-21 | 1999-01-05 | Bristol-Myers Squibb Co. | Methods for the preparation of biphenyl isoxazole sulfonamides |
US5939446A (en) * | 1996-04-09 | 1999-08-17 | Bristol-Myers Squibb Co. | Heteroaryl substituted phenyl isoxazole sulfonamide endothelin antagonists |
US6245773B1 (en) | 1996-05-16 | 2001-06-12 | Synaptic Pharmaceutical Corporation | 5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines |
US6172066B1 (en) | 1996-05-16 | 2001-01-09 | Synaptic Pharmaceutical Corporation | Dihydropyrimidines and uses thereof |
US5985830A (en) * | 1996-09-16 | 1999-11-16 | Dalhousie University | Use of IGF-I for the treatment of kidney disorders |
WO1998033781A1 (en) * | 1997-01-30 | 1998-08-06 | Bristol-Myers Squibb Company | Method for preventing or treating low renin hypertension by administering an endothelin antagonist |
TW536540B (en) * | 1997-01-30 | 2003-06-11 | Bristol Myers Squibb Co | Endothelin antagonists: N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide and N-(4,5-dimethyl-3-isoxazolyl)-2'-[(3,3-dimethyl-2-oxo-1-pyrrolidinyl)methyl]-4'-(2-oxazolyl)[1,1'-biphe |
US6680323B2 (en) | 1998-12-23 | 2004-01-20 | Synaptic Pharmaceutical Corporation | Dihydropyrimidines and uses thereof |
US6274585B1 (en) | 1998-12-23 | 2001-08-14 | Synaptic Pharmaceutical Corporation | Dihydropyrimidines and uses thereof |
US7566452B1 (en) | 1999-05-04 | 2009-07-28 | New York University | Cancer treatment with endothelin receptor antagonists |
CA2315614C (en) * | 1999-07-29 | 2004-11-02 | Pfizer Inc. | Pyrazoles |
WO2001081338A1 (en) * | 2000-04-25 | 2001-11-01 | Actelion Pharmaceuticals Ltd | Substituted sulfonylaminopyrimidines |
US6720324B2 (en) | 2000-07-05 | 2004-04-13 | Synaptic Pharmaceutical Corporation | Selective melanin concentrating hormone-1 (MCH1) receptor antagonists and uses thereof |
MY140724A (en) | 2000-07-21 | 2010-01-15 | Actelion Pharmaceuticals Ltd | Novel arylethene-sulfonamides |
US6670362B2 (en) | 2000-09-20 | 2003-12-30 | Pfizer Inc. | Pyridazine endothelin antagonists |
JP2004509874A (ja) | 2000-09-25 | 2004-04-02 | アクテリオン ファマシューティカルズ リミテッド | 新規なアリールアルカン−スルフォンアミド類 |
US6639082B2 (en) | 2000-10-17 | 2003-10-28 | Bristol-Myers Squibb Company | Methods for the preparation of biphenyl isoxazole sulfonamides |
KR100374326B1 (ko) * | 2000-11-29 | 2003-03-03 | 한국과학기술연구원 | 6-히드록시-1, 3-디옥신-4-온 고리를 가진인간면역결핍바이러스 프로테아제 억제 화합물 및 그의제조방법 |
CN100432070C (zh) | 2000-12-18 | 2008-11-12 | 埃科特莱茵药品有限公司 | 新颖的磺酰胺类化合物及其作为内皮素受体拮抗剂的应用 |
WO2002083650A1 (en) * | 2001-04-11 | 2002-10-24 | Actelion Pharmaceuticals Ltd | Novel sulfonylamino-pyrimidines |
AU2011218661B2 (en) * | 2002-05-24 | 2012-07-05 | Millennium Pharmaceuticals, Inc. | CCR9 inhibitors and methods of use thereof |
JP4828822B2 (ja) * | 2002-05-24 | 2011-11-30 | ミレニアム ファーマシューティカルズ, インコーポレイテッド | Ccr9インヒビターおよびその使用方法 |
US7227035B2 (en) * | 2002-11-18 | 2007-06-05 | Chemocentryx | Bis-aryl sulfonamides |
DE60314175T2 (de) * | 2002-11-18 | 2008-01-24 | Chemocentryx Inc., Mountain View | Arylsulfonamide |
US7741519B2 (en) | 2007-04-23 | 2010-06-22 | Chemocentryx, Inc. | Bis-aryl sulfonamides |
US7420055B2 (en) | 2002-11-18 | 2008-09-02 | Chemocentryx, Inc. | Aryl sulfonamides |
ES2320649T3 (es) | 2002-12-02 | 2009-05-27 | Actelion Pharmaceuticals Ltd. | Pirimidin-sulfamidas y su uso como antagonistas de receptores de endotelina. |
DE102004027119A1 (de) | 2003-06-06 | 2004-12-30 | Schott Ag | UV-Strahlung absorbierendes Glas mit geringer Absorption im sichtbaren Bereich, ein Verfahren zu seiner Herstellung sowie dessen Verwendung |
WO2005095359A1 (en) * | 2004-03-05 | 2005-10-13 | F. Hoffmann-La Roche Ag | Diaminopyrimidines as p2x3 and p2x2/3 antagonists |
EP1737845A4 (en) * | 2004-04-13 | 2010-07-21 | Synta Pharmaceuticals Corp | DISPLAY HEMMER OF IL-12 PRODUCTION |
KR100847203B1 (ko) * | 2004-06-28 | 2008-07-17 | 에프. 호프만-라 로슈 아게 | 피리미딘 유도체 |
CN1972918B (zh) | 2004-06-28 | 2010-10-13 | 霍夫曼-拉罗奇有限公司 | 嘧啶衍生物 |
TW200628467A (en) | 2004-11-11 | 2006-08-16 | Actelion Pharmaceuticals Ltd | Novel sulfamides |
CN101300235B (zh) | 2005-09-01 | 2011-12-07 | 弗·哈夫曼-拉罗切有限公司 | 作为p2x3和p2x2/3调节剂的二氨基嘧啶类化合物 |
CN101253159B (zh) * | 2005-09-01 | 2011-12-07 | 弗·哈夫曼-拉罗切有限公司 | 作为p2x3和p2x2/3调节剂的二氨基嘧啶类化合物 |
EP1924564B1 (en) * | 2005-09-01 | 2016-11-09 | F.Hoffmann-La Roche Ag | Diaminopyrimidines as p2x3 and p2x2/3 modulators |
EP2001446A2 (en) * | 2006-03-13 | 2008-12-17 | Encysive Pharmaceuticals, Inc | Formulations of sitaxsentan sodium |
KR20080104149A (ko) * | 2006-03-13 | 2008-12-01 | 엔싸이시브 파마슈티칼즈 인코퍼레이티드 | 확장기 심장 부전의 치료를 위한 방법 및 조성물 |
US20080026061A1 (en) * | 2006-06-22 | 2008-01-31 | Reichwein John F | Crystalline N-(4-chloro-3-methyl-5-isoxazolyl)-2-[2-methyl-4.5-(methylenedioxy)phenylacetyl]-thiophene-3-sulfonamide |
AR062501A1 (es) | 2006-08-29 | 2008-11-12 | Actelion Pharmaceuticals Ltd | Composiciones terapeuticas |
EP3000487B8 (en) * | 2007-02-19 | 2022-06-15 | Marine Polymer Technologies, Inc. | Hemostatic compositions and therapeutic regimens |
MX2010001837A (es) | 2007-08-17 | 2010-03-10 | Actelion Pharmaceuticals Ltd | Derivados de 4-pirimidinasulfamida. |
US8858964B2 (en) | 2010-04-15 | 2014-10-14 | Marine Polymer Technologies, Inc. | Anti-bacterial applications of poly-N-acetylglucosamine nanofibers |
NZ715595A (en) | 2011-04-15 | 2017-06-30 | Marine Polymer Tech Inc | Treatment of disease with poly-n-acetyglucosamine nanofibers |
RU2604060C1 (ru) * | 2015-10-06 | 2016-12-10 | федеральное государственное бюджетное образовательное учреждение высшего образования "Санкт-Петербургская государственная химико-фармацевтическая академия" Министерства здравоохранения Российской Федерации (ФГБОУ ВО СПХФА Минздрава России) | Способ получения 2,5-дизамещенных 6-гидроксипиримидин-4(3н)-онов |
AR107928A1 (es) | 2016-03-22 | 2018-06-28 | Merck Sharp & Dohme | Moduladores alostéricos de receptores de acetilcolina nicotínicos |
RU2643356C2 (ru) * | 2016-06-22 | 2018-02-01 | федеральное государственное бюджетное образовательное учреждение высшего образования "Волгоградский государственный медицинский университет" Министерства здравоохранения Российской Федерации | Новое n-арилсульфамидное производное о-бензоиламинобензойной кислоты, обладающее анксиолитической, актопротекторной и антидепрессивной активностью |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0210526B1 (de) | 1985-07-24 | 1989-05-24 | Siemens Aktiengesellschaft | Kernreaktorbrennelement |
TW270116B (ru) * | 1991-04-25 | 1996-02-11 | Hoffmann La Roche | |
RU2086544C1 (ru) | 1991-06-13 | 1997-08-10 | Хоффманн-Ля Рош АГ | Бензолсульфонамидные производные пиримидина или их соли, фармацевтическая композиция для лечения заболеваний, связанных с активностью эндотелина |
TW287160B (ru) * | 1992-12-10 | 1996-10-01 | Hoffmann La Roche |
-
1994
- 1994-06-08 TW TW083105221A patent/TW394761B/zh not_active IP Right Cessation
- 1994-06-13 CA CA002125730A patent/CA2125730C/en not_active Expired - Fee Related
- 1994-06-16 DE DE59407626T patent/DE59407626D1/de not_active Expired - Lifetime
- 1994-06-16 ES ES94109257T patent/ES2127850T3/es not_active Expired - Lifetime
- 1994-06-16 EP EP94109257A patent/EP0633259B1/de not_active Expired - Lifetime
- 1994-06-16 DK DK94109257T patent/DK0633259T3/da active
- 1994-06-16 SG SG1996004116A patent/SG43888A1/en unknown
- 1994-06-16 AT AT94109257T patent/ATE175669T1/de active
- 1994-06-16 SI SI9430236T patent/SI0633259T1/xx unknown
- 1994-06-21 ZA ZA944434A patent/ZA944434B/xx unknown
- 1994-06-22 IL IL11008994A patent/IL110089A/xx not_active IP Right Cessation
- 1994-06-24 AU AU65948/94A patent/AU678467B2/en not_active Ceased
- 1994-06-24 NZ NZ260842A patent/NZ260842A/en unknown
- 1994-06-24 HU HU9401907A patent/HUT67636A/hu unknown
- 1994-06-24 HR HR01924/93-6A patent/HRP940370B1/xx not_active IP Right Cessation
- 1994-06-24 IS IS4185A patent/IS4185A/is unknown
- 1994-06-27 PL PL94304007A patent/PL175771B1/pl unknown
- 1994-06-27 CO CO94027814A patent/CO4230230A1/es unknown
- 1994-06-27 PL PL94323036A patent/PL177031B1/pl unknown
- 1994-06-27 LV LVP-94-131A patent/LV11175B/lv unknown
- 1994-06-27 UA UA94005281A patent/UA40578C2/ru unknown
- 1994-06-27 PH PH48525A patent/PH30688A/en unknown
- 1994-06-27 RU RU94022258/04A patent/RU2142457C1/ru not_active IP Right Cessation
- 1994-06-27 FI FI943084A patent/FI112944B/fi not_active IP Right Cessation
- 1994-06-27 LT LTIP1979A patent/LT3723B/lt not_active IP Right Cessation
- 1994-06-27 CN CN94106574A patent/CN1050839C/zh not_active Expired - Fee Related
- 1994-06-27 EC EC1994001111A patent/ECSP941111A/es unknown
- 1994-06-27 BG BG98880A patent/BG61691B1/bg unknown
- 1994-06-27 US US08/266,072 patent/US5541186A/en not_active Expired - Lifetime
- 1994-06-27 KR KR1019940014774A patent/KR100338905B1/ko not_active IP Right Cessation
- 1994-06-27 YU YU40794A patent/YU40794A/sh unknown
- 1994-06-27 PE PE1994245279A patent/PE56794A1/es not_active Application Discontinuation
- 1994-06-27 BR BR9402558A patent/BR9402558A/pt not_active Application Discontinuation
- 1994-06-27 CZ CZ19941573A patent/CZ287184B6/cs not_active IP Right Cessation
- 1994-06-27 NO NO942428A patent/NO306403B1/no unknown
- 1994-06-27 MY MYPI94001661A patent/MY110871A/en unknown
- 1994-06-27 UY UY23797A patent/UY23797A1/es not_active IP Right Cessation
- 1994-06-28 RO RO94-01112A patent/RO114325B1/ro unknown
- 1994-06-28 SV SV1994B00028A patent/SV1994000028A/es not_active Application Discontinuation
- 1994-06-28 SK SK779-94A patent/SK280736B6/sk unknown
- 1994-06-28 JP JP6146003A patent/JP2545200B2/ja not_active Expired - Fee Related
-
1995
- 1995-06-21 HU HU95P/P00298P patent/HU211533A9/hu unknown
-
1996
- 1996-12-05 BR BR1100089-9A patent/BR1100089A/pt active IP Right Grant
-
1999
- 1999-04-05 GR GR990400963T patent/GR3029874T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU94022258A (ru) | Новые сульфониламинопиримидины | |
NO308794B1 (no) | Farmakologisk aktive pyridin-derivater, preparater inneholdende forbindelsene samt forbindelsenes anvendelse | |
MX9702380A (es) | Nuevas carboxamidas con actividad antifungica. | |
RU94036758A (ru) | Применение 2-фенил-3-ароилбензотиофенов для лечения пери-менопаузного синдрома | |
RU94029662A (ru) | Фосфонооксиметиловые эфиры производных таксана, фармацевтическая композиция, способы лечения | |
RU94044436A (ru) | Способы подавления атрофии кожи и влагалища | |
ATE299890T1 (de) | Inhibitoren von gamma-secretase | |
RU94031102A (ru) | Сульфамиды в качестве антагонистов эндотелина и способ лечения соответствующих заболеваний | |
RU94045846A (ru) | Применение производных бензотиофена для ингибирования тромбина | |
GEP20012578B (en) | (54) Heteroaryl Succinamides, Pharmaceutical Compositions Containing the Same and Methods for Treatment of the Diseases Caused by Metalloproteinase Activity | |
SE9504661D0 (sv) | New compounds | |
EA200401522A1 (ru) | Противотуберкулёзный препарат: композиции и способы | |
MX9702382A (es) | Nuevos derivados de pirimidona con actividad antifungica. | |
BG103399A (en) | New heterocycle-substituted benzamides and their application for the treatment of diseases | |
RU94045149A (ru) | Средство ингибирования легочных гипертонических заболеваний | |
DE69623899D1 (de) | Behandlung von Tinnitus mit neuroprotektiven Wirkstoffen | |
RU94044490A (ru) | Применение 2-фенил-3-ароилбензотиофенов для подавления дефектного восстановления ткани | |
RU94038064A (ru) | Производные пиперазина и пиперидина, их применение в качестве противопсихотических средств, способ их получения фармацевтическая композиция | |
RU94044453A (ru) | Применение 2-фенил-3-ароилбензотиофенов для ингибирования себореи и угрей | |
RU94044454A (ru) | Ингибитор аутоимунных заболеваний | |
RU94037233A (ru) | Применение 2-фенил-3-ароилбензотиофенов для лечения лекарственноустойчивых новообразований | |
RU95105435A (ru) | N-замещенные производные 3-азабицикло [3.2.0]гептана в качестве нейролептического средства | |
RU94044321A (ru) | Средство повышения либидо у женщин постклимактерического периода | |
RU94044489A (ru) | Применение 2-фенил-3-ароилбензотиофенов для ингибирования миелопероксидазной активности | |
UA27910C2 (ru) | Средство для повышения экспрессии тромбомодулина и повышения активации протеина с |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20030628 |